These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37788370)

  • 21. Recovery of miR-139-5p in Ovarian Cancer Reverses Cisplatin Resistance by Targeting C-Jun.
    Jiang Y; Jiang J; Jia H; Qiao Z; Zhang J
    Cell Physiol Biochem; 2018; 51(1):129-141. PubMed ID: 30439707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LINC00707 promotes cell proliferation and invasion of colorectal cancer via miR-206/FMNL2 axis.
    Shao HJ; Li Q; Shi T; Zhang GZ; Shao F
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3749-3759. PubMed ID: 31115001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ΜiR-182-5p functions as a tumor suppressor to sensitize human ovarian cancer cells to cisplatin through direct targeting the cyclin dependent kinase 6 (CDK6).
    Duan L; Yan Y; Wang G; Xing YL; Sun J; Wang LL
    J BUON; 2020; 25(5):2279-2286. PubMed ID: 33277846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA OIP5-AS1 plays an oncogenic role in ovarian cancer through targeting miR-324-3p/NFIB axis.
    Liu QY; Jiang XX; Tian HN; Guo HL; Guo H; Guo Y
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7266-7275. PubMed ID: 32706064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linc00707 promotes cell proliferation, invasion, and migration via the miR-30c/CTHRC1 regulatory loop in breast cancer.
    Yuan RX; Bao D; Zhang Y
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4863-4872. PubMed ID: 32432749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p.
    Aichen Z; Kun W; Xiaochun S; Lingling T
    Apoptosis; 2021 Jun; 26(5-6):348-360. PubMed ID: 33974163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing of long noncoding RNA RP11-476D10.1 enhances apoptosis and autophagy while inhibiting proliferation of papillary thyroid carcinoma cells via microRNA-138-5p-dependent inhibition of LRRK2.
    Zhao Y; Zhao L; Li J; Zhong L
    J Cell Physiol; 2019 Nov; 234(11):20980-20991. PubMed ID: 31102261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The lncRNA SNHG15/miR-18a-5p axis promotes cell proliferation in ovarian cancer through activating Akt/mTOR signaling pathway.
    Zhang J; Wang L; Jiang J; Qiao Z
    J Cell Biochem; 2020 Dec; 121(12):4699-4710. PubMed ID: 33135285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LINC00707 Regulates miR-382-5p/VEGFA Pathway to Enhance Cervical Cancer Progression.
    Guo H; Li J; Fan F; Zhou P
    J Immunol Res; 2021; 2021():5524632. PubMed ID: 34258298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linc00161 regulated the drug resistance of ovarian cancer by sponging microRNA-128 and modulating MAPK1.
    Xu M; Zhou K; Wu Y; Wang L; Lu S
    Mol Carcinog; 2019 Apr; 58(4):577-587. PubMed ID: 30556928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoting action of long non-coding RNA small nucleolar RNA host gene 4 in ovarian cancer.
    Liu C; Zhao S; Lv ZX; Zhao XJ
    Acta Biochim Pol; 2023 Jan; 70(1):59-68. PubMed ID: 36657061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of long noncoding RNA TUSC7 promoted cell growth, invasion and migration through sponging with miR-616-5p/GSK3β pathway in ovarian cancer.
    Zhu LM; Li N
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7253-7265. PubMed ID: 32706063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
    Yang X; Xin N; Qu HJ; Wei L; Han Z
    Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA KCNQ1OT1 accelerates ovarian cancer progression via miR-125b-5p/CD147 axis.
    Chen P; Sun LS; Shen HM; Qu B
    Pathol Res Pract; 2022 Nov; 239():154135. PubMed ID: 36191448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LINC00707 knockdown inhibits IL-1β-induced apoptosis and extracellular matrix degradation of osteoarthritis chondrocytes by the miR-330-5p/FSHR axis.
    Qian M; Shi Y; Lu W
    Immunopharmacol Immunotoxicol; 2022 Oct; 44(5):671-681. PubMed ID: 35536095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circ_0078607 inhibits the progression of ovarian cancer via regulating the miR-32-5p/SIK1 network.
    Jin Y; Wang H
    J Ovarian Res; 2022 Jan; 15(1):3. PubMed ID: 34983607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin Affects Paclitaxel Sensitivity of Ovarian Cancer Cells Through Autophagy Mediated by Long Noncoding RNASNHG7/miR-3127-5p Axis.
    Yu Z; Wang Y; Wang B; Zhai J
    Cancer Biother Radiopharm; 2022 Nov; 37(9):792-801. PubMed ID: 32522016
    [No Abstract]   [Full Text] [Related]  

  • 38. miR-106a-5p carried by tumor-derived extracellular vesicles promotes the invasion and metastasis of ovarian cancer by targeting KLF6.
    Zheng Y; Zhu K; Wang G
    Clin Exp Metastasis; 2022 Aug; 39(4):603-621. PubMed ID: 35449340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes.
    Li X; Chen W; Jin Y; Xue R; Su J; Mu Z; Li J; Jiang S
    Biochem Pharmacol; 2019 Mar; 161():98-112. PubMed ID: 30639456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. F-Box and Leucine-Rich Repeat Protein 20 (FBXL20), Negatively Regulated by microRNA (miR)-195-5p, Accelerates the Malignant Progression of Ovarian Cancer.
    Wu D; Liu C; Hong L
    Mol Biotechnol; 2021 Dec; 63(12):1235-1243. PubMed ID: 34338995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.